Baxter Reports US Launch Of Premix Drug VANCOMYCIN Injection In Sodium Chloride

(RTTNews) - Baxter International Inc. (BAX) announced the launch of a ready-to-use VANCOMYCIN injection in 0.9% Sodium Chloride (Normal Saline) in 500 mg, 750 mg and 1 gram presentations. VANCOMYCIN injection is an antibiotic used to treat serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci bacteria.

VANCOMYCIN saline injection augments Baxter's expanding portfolio of generic injectable drugs in the United States available in easy-to-use presentations that hospitals, physicians and patients can rely on because they are manufactured to the Current Good Manufacturing Practice (cGMP) regulations established by the U.S. Food and Drug Administration (FDA). Premixed medications in standardized drug concentrations can help support hospitals' goals for safe and efficient medication preparation because compounding is not necessary.

The launch is an extension of Baxter's existing VANCOMYCIN injection in 5% dextrose in 500 mg, 750 mg and 1 gram presentations and provides an alternative to certain patients who may need to avoid receiving additional dextrose.

Baxter's VANCOMYCIN saline injection in 500 mg, 750 mg and 1 gram presentations are available in the United States.